DiaVacs
La Jolla, US · Founded 2013 · Delaware corporation · 1 known investors
Find your way into DiaVacs
DiaVacs is a biotechnology company developing cell-based immunotherapies, focused on tolerogenic dendritic cell approaches for Type 1 diabetes and applications related to SARS-CoV-2. Its work draws on research in cellular therapeutics and immune tolerance, supported by a scientific advisory board of diabetes and immunology researchers.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$850K disclosed across 1 round · 2015
▶$850KraisedMar 2015 · 10 investors · OtherRule 506(b)
- James GavinDirector
- Edwin NaylorDirector
- Daniel BradburyExecutive Officer, Director
- Alan LewisDirector
- Vern NorvielExecutive Officer
- Alexander CasdinDirector
- Offering amount
- $4M
- Amount sold
- $850K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with DiaVacs for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $231.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does DiaVacs do?
- DiaVacs is a biotechnology company developing cell-based immunotherapies, focused on tolerogenic dendritic cell approaches for Type 1 diabetes and applications related to SARS-CoV-2. Its work draws on research in cellular therapeutics and immune tolerance, supported by a scientific advisory board of diabetes and immunology researchers.
- Who are DiaVacs's investors?
- DiaVacs's investors include Blackbird Ventures.
- How much funding has DiaVacs raised?
- DiaVacs has disclosed $850K raised across 1 round.
- Where is DiaVacs headquartered?
- DiaVacs is headquartered in La Jolla, US.